The Current Ratio as of November 2024 (TTM) for PMV Pharmaceuticals, Inc. (PMVP) is 13.98

According to PMV Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 13.98. This represents a change of -13.66% compared to the average of 16.19 of the last 4 quarters.

PMV Pharmaceuticals, Inc. (PMVP) Historical Current Ratio (quarterly & annually)

How has PMVP Current Ratio performed in the past?

The mean historical Current Ratio of PMV Pharmaceuticals, Inc. over the last ten years is 28.08. The current 13.98 Current Ratio has changed 4.88% with respect to the historical average. Over the past ten years (40 quarters), PMVP's Current Ratio was at its highest in in the September 2020 quarter at 68.24. The Current Ratio was at its lowest in in the March 2019 quarter at 0.

PMV Pharmaceuticals, Inc. (PMVP) Current Ratio by Quarter and Year

Discovering the peaks and valleys of PMV Pharmaceuticals, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

PMV Pharmaceuticals, Inc. (PMVP) Average Current Ratio

How has PMVP Current Ratio performed in the past?

The current Current Ratio of PMV Pharmaceuticals, Inc. (PMVP) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

PMV Pharmaceuticals, Inc. (PMVP) Current Ratio vs. Peers

How is PMVP’s Current Ratio compared to its peers?

PMV Pharmaceuticals, Inc.’s Current Ratio is less than Eliem Therapeutics, Inc. (60.41), less than MediciNova, Inc. (16.66), less than Pharvaris N.V. (19.08), greater than PepGen Inc. (8.47), greater than Anebulo Pharmaceuticals, Inc. (3.45), greater than Acrivon Therapeutics, Inc. Common Stock (12.75), less than Molecular Partners AG (14.33), greater than Mineralys Therapeutics, Inc. (8.55), less than Edgewise Therapeutics, Inc. (26.35), greater than Rallybio Corporation (9.55), greater than Opthea Limited (2.94), greater than Monte Rosa Therapeutics, Inc. (6.03), greater than Entrada Therapeutics, Inc. (6.59), greater than Vigil Neuroscience, Inc. (3.72),

Build a custom stock screener for PMV Pharmaceuticals, Inc. (PMVP) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like PMV Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

PMV Pharmaceuticals, Inc. (PMVP) and other stocks custom spreadsheet templates

The easiest way to analyze a company like PMV Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.